Citicoline in hypoxic ischemic encephalopathy in neonates: a randomized controlled trial

BACKGROUND: Hypoxic-ischemic encephalopathy (HIE) is one of the major complications that can lead to death or disability in neonates. We assessed the effect of citicoline as a neuroprotector in neonates with moderate and severe HIE. METHODS: This clinical trial was carried on 80 neonates with modera...

Descripción completa

Detalles Bibliográficos
Autores principales: Salamah, Abeer, El Amrousy, Doaa, Elsheikh, Mai, Mehrez, Mostafa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182621/
https://www.ncbi.nlm.nih.gov/pubmed/37173784
http://dx.doi.org/10.1186/s13052-023-01452-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182621/
https://www.ncbi.nlm.nih.gov/pubmed/37173784
http://dx.doi.org/10.1186/s13052-023-01452-5

Ejemplares similares